cobas liat CT/NG/MG nucleic acid test— 510(k) K253759
Substantially EquivalentRoche Molecular Systems, Inc.
FDA 510(k) clearance K253759 for cobas liat CT/NG/MG nucleic acid test, Substantially Equivalent on 2026-05-15. Applicant: Roche Molecular Systems, Inc.. Device class: 2.
Summary
The cobas liat CT/NG/MG nucleic acid test is from Roche Molecular Systems, filed under QEP, nucleic acid detection systems for non-viral microorganisms causing sexually transmitted infections. The record doesn't expand "CT/NG/MG".
Class II, 21 CFR 866.3393. Microbiology is both the classification panel and the review panel, and the record lists the submission type as Dual Track.
Roche filed from Pleasanton, California. Review took 171 calendar days (November 25, 2025 to May 15, 2026).
Clearance details
- Applicant
- Roche Molecular Systems, Inc.
- Product code
- Product code QEP
- Device class
- Class 2
- Regulation
- 21 CFR 866.3393
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Dual Track
- Location
- Pleasanton, CA, US
Recent devices under product code QEP
view allMore clearances from Roche Molecular Systems, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.